CHEMID

Chemed Corporation

HealthcareMedical - Care Facilities
$444.11
$0.08(+1.84%)
52W$365.20
$562.77
Updated Jun 24, 02:00 AM
RSI55
RS Rating60/99
Beta0.18
Volatility33%
F-Score5/9
Mkt Cap$6.1B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Chemed Corporation is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 60), indicating performance broadly in line with the market. Earnings contraction of 0% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
60
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.18
vs S&P 500
LOW VOL
52W Position
40%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$421.45
50 SMA > 100 SMA$418.99
100 SMA > 150 SMA$424.76
150 SMA > 200 SMA$429.75

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$432.69+2.64%ABOVE
50 SMA$421.45+5.38%ABOVE
100 SMA$418.99+5.99%ABOVE
150 SMA$424.76+4.56%ABOVE
200 SMA$429.75+3.34%ABOVE

Price Performance

1D+1.8%
1W+2.4%
1M+1.6%
3M+18.9%
6M+2.6%
YTD+4.8%
1Y-19.5%
3Y-6.4%
52-Week Trading Range40% from low
$444.11
52W Low$365.20
52W High$562.77

Technical Indicators

RSI (14)NEUTRAL
55.1
305070
Setup ScoreCOOL
4/10
Base depth: 19.5%

Risk Profile

Beta
0.18
52W Vol
33%
ATR
$12.86
Max DD (1Y)
-34%

Volume Analysis

Today
240.0K
50D Avg
219.0K
Vol Ratio
1.10x
Liquidity
LIQUID

Earnings Momentum

Q2'25-23%
$3.57
Q3'25-11%
$4.46
Q4'25-9%
$5.48
Q1'260%
$4.85
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+5.07%
5 Years:+4.00%
3 Years:+5.82%
TTM:+2.07%

Compounded Profit Growth

10 Years:+11.27%
5 Years:-1.11%
3 Years:+3.67%
TTM:-10.66%

Stock Price CAGR

10 Years:+12.73%
5 Years:-1.59%
3 Years:-6.42%
1 Year:-19.48%

Return on Equity

10Y Avg:30.0%
5Y Avg:30.3%
3Y Avg:27.0%
Last Year:25.3%

Key Metrics

Market Cap$6.1B
Gross Margin30.0%
Net Margin10.5%
Piotroski F-Score5/9

Frequently Asked Questions

Is CHE in an uptrend right now?

CHE has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is CHE overbought or oversold?

CHE's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.

Is CHE outperforming the market?

CHE has a Relative Strength (RS) Rating of 60 out of 99. CHE is performing about average compared to the market.

Where is CHE in its 52-week range?

CHE is trading at $444.11, which is 79% of its 52-week high ($562.77) and 40% above its 52-week low ($365.20).

How volatile is CHE?

CHE has a Beta of 0.18 and 52-week volatility of 33%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.